Clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing–remitting multiple sclerosis (RRMS)- An integrated analysis of the phase 3 define and confirm studies

May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.481
https://www.valueinhealthjournal.com/article/S1098-3015(13)00552-4/fulltext
Section Title : Neurological Disorders
Section Order : 23
First Page : A102
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00552-4&doi=10.1016/j.jval.2013.03.481
HEOR Topics :
Tags :
Regions :